Our Commitment to Beat Coronavirus

Our Commitment to Beat Coronavirus

Pharmaceutical companies are committed to developing solutions to help diagnose and treat those with COVID-19.

In these unprecedented times, we are coming together to achieve one shared goal: to beat COVID-19. The decades-long investments we have made in new technology, research and treatments have prepared us to act swiftly:

  • We are rapidly screening our vast global libraries of medicines to identify potential treatments and have numerous clinical trials underway to test new and existing therapies.
  • We are dedicating our top scientists and using our investments in new technologies to speed the development of safe and effective vaccines.
  • We are sharing the learnings from clinical trials in real time with governments and other companies to advance the development of additional therapies.
  • We are expanding our unique manufacturing capabilities and sharing available capacity to ramp up production once a successful medicine or vaccine is developed.
  • In addition to applying our scientific expertise to find ways to diagnose, treat and prevent infections from the virus, we provide financial support and in-kind donations to organizations, hospitals, etc.
  • We are working with Greek government, other governments and global health authorities to ensure that when new treatments and vaccines are approved, they will be available for all those who need them.